ANDREUCCI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 1.279
NA - Nord America 1.212
AS - Asia 256
SA - Sud America 2
Totale 2.749
Nazione #
US - Stati Uniti d'America 1.206
PL - Polonia 777
IT - Italia 209
IE - Irlanda 126
HK - Hong Kong 89
SE - Svezia 64
CN - Cina 55
JO - Giordania 38
VN - Vietnam 35
IN - India 27
RU - Federazione Russa 22
CH - Svizzera 13
DE - Germania 13
GB - Regno Unito 13
BE - Belgio 8
SG - Singapore 8
FR - Francia 7
CA - Canada 5
ES - Italia 5
FI - Finlandia 5
AT - Austria 4
CZ - Repubblica Ceca 4
UA - Ucraina 4
SK - Slovacchia (Repubblica Slovacca) 3
CL - Cile 2
TR - Turchia 2
CR - Costa Rica 1
DK - Danimarca 1
JP - Giappone 1
PK - Pakistan 1
RS - Serbia 1
Totale 2.749
Città #
Warsaw 777
Fairfield 214
Chandler 147
Ashburn 131
Dublin 126
Seattle 83
Woodbridge 80
Florence 75
Houston 68
Hong Kong 62
Cambridge 59
Wilmington 59
Ann Arbor 45
Beijing 37
Altamura 35
Lawrence 35
Dong Ket 30
Princeton 29
Buffalo 21
Pune 21
Boston 19
Moscow 17
Shanghai 14
San Diego 13
Pisa 12
Falls Church 11
Bern 10
Phoenix 9
Medford 8
New York 8
Singapore 7
Gavirate 6
Bari 5
Boardman 5
Brussels 5
Hillsboro 5
Norwalk 5
Redwood City 5
Toronto 5
Arezzo 4
Barcelona 4
Olomouc 4
Rome 4
Vienna 4
Bratislava 3
Brescia 3
Frankfurt am Main 3
Guwahati 3
Hanoi 3
London 3
Louvain-la-Neuve 3
Andover 2
Bologna 2
Bursa 2
Fiesole 2
Genoa 2
Iquique 2
Irkutsk 2
Macerata 2
Masate 2
Munich 2
Prato 2
Redmond 2
Suwanee 2
Zhengzhou 2
Arnsberg 1
Avellino 1
Belgrade 1
Bremen 1
Central 1
Chandigarh 1
Chengdu 1
Copenhagen 1
East Dulwich 1
Fabriano 1
Gurgaon 1
Hangzhou 1
Helsinki 1
Kyoto 1
Lahore 1
Linköping 1
Madrid 1
Manipal 1
Milan 1
Misano Adriatico 1
Molinella 1
Montevarchi 1
Padova 1
Paris 1
Perm 1
Prescot 1
San José 1
San Lazzaro Di Savena 1
Signa 1
Slough 1
Velikiy Novgorod 1
Washington 1
Wernigerode 1
Totale 2.405
Nome #
The acidic microenvironment as a possible niche of dormant tumor cells 242
Type II CRISPR/Cas9 approach in the oncological therapy 205
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 172
Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies 171
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 159
Acidity of Microenvironment as a Further Driver of Tumor Metabolic Reprogramming 158
SOX2 as a novel contributor of oxidative metabolism in melanoma cells 143
Anoikis resistance as a further trait of acidic-adapted melanoma cells 128
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 126
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer 117
Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells 104
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis 103
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 98
FDG uptake in cancer: a continuing debate 89
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells 88
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells 75
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 72
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 67
FGF2 in Human Melanoma Progression: The Antithetical Functions of Different Isoforms 53
Fenotipo Turner associato ad una delezione interstiziale sul braccio lungo del cromosoma 2 42
Oleuropein affects braf melanoma cells and potentiates chemotherapy cytotoxicity 41
Enhanced vasculogenic capacity induced by 5-fluorouracil chemoresistance in a gastric cancer cell line 38
Oleuropein potentiates the cytotoxic activity of dacarbazine against melanoma cells. 37
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 37
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 31
Local modulation of thyroid hormone signaling in the retina affects the development of diabetic retinopathy 28
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy 27
Nintedanib-Containing Dual Conjugates Targeting αVβ6 Integrin and Tyrosine Kinase Receptors as Potential Antifibrotic Agents 26
miR-214-enriched extracellular vesicles released by acid-adapted melanoma cells promote inflammatory macrophage-dependent tumor trans-endothelial migration 25
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 24
uPAR controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells. 23
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs 22
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 16
Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry 13
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 6
Totale 2.806
Categoria #
all - tutte 8.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019127 0 0 0 0 0 0 0 0 0 29 51 47
2019/2020643 33 56 15 37 86 60 66 85 61 53 87 4
2020/2021641 39 85 15 88 38 39 66 49 55 106 26 35
2021/2022231 25 39 8 8 8 14 7 15 7 22 32 46
2022/2023626 46 111 35 47 42 106 73 44 81 7 18 16
2023/2024337 3 29 33 17 21 66 28 106 12 22 0 0
Totale 2.806